Trial Profile
Phase II Study of KRP-209 - A Clinical Trial to Evaluate Efficacy and Safety of KRP-209 in Patients with Subjective Tinnitus -
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2018
Price :
$35
*
At a glance
- Drugs Neramexane (Primary)
- Indications Tinnitus
- Focus Therapeutic Use
- Sponsors Kyorin Pharmaceutical
- 24 Jun 2014 New trial record